Wednesday, July 8, 2026

pharma · Urothelial Carcinoma Bladder · Castration Resistant Metastatic Prostate Cancer · AKTS

Aktis Oncology

Aktis Oncology trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Cambridge, USA HQ
90 Employees
Public company Type
AKTS · NYSE Ticker
Company details
Status
Public
HQ
Cambridge, USA
Employees
90
Programs
2
Drugs
0
Patents
1
Intelligence · Clinical Trials

Aktis Oncology clinical trials

Registry index of 2 ClinicalTrials.gov studies linked to Aktis Oncology programs — each row shows trial ID, program name, phase, status, and indication.

Aktis Oncology trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

2 updates

Latest clinical program signals indexed for Aktis Oncology.

  1. [225Ac]Ac-AKY-1189 (therapeutic) — Phase 1

    Clinical update
  2. [225Ac]Ac-AKY-2519 (therapeutic) — Phase 1

    Clinical update

Trial registry

2 studies